1016TiP LEAP-012 trial in progress: Pembrolizumab plus lenvatinib and transarterial chemoembolization (TACE) in patients with intermediate-stage hepatocellular carcinoma (HCC) not amenable to curative treatment
| Autor: | Llovet, J.M., El-Khoueiry, A.B., Vogel, A., Madoff, D.C., Finn, R.S., Ogasawara, S., Ren, Z., Mody, K., Li, J. Jing, Siegel, A.B., Dubrovsky, L., Kudo, M. |
|---|---|
| Zdroj: | In Annals of Oncology September 2020 31 Supplement 4:S702-S703 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|